Pasithea Therapeutics (KTTA) Interest & Investment Income (2022 - 2024)
Historic Interest & Investment Income for Pasithea Therapeutics (KTTA) over the last 3 years, with Q4 2024 value amounting to $80483.0.
- Pasithea Therapeutics' Interest & Investment Income fell 5343.09% to $80483.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $423184.0, marking a year-over-year change of. This contributed to the annual value of $423184.0 for FY2024, which is 188.17% up from last year.
- Latest data reveals that Pasithea Therapeutics reported Interest & Investment Income of $80483.0 as of Q4 2024, which was down 5343.09% from $75076.0 recorded in Q3 2024.
- Pasithea Therapeutics' 5-year Interest & Investment Income high stood at $172825.0 for Q4 2023, and its period low was -$335317.0 during Q3 2022.
- Its 3-year average for Interest & Investment Income is $56061.7, with a median of $114407.0 in 2024.
- Per our database at Business Quant, Pasithea Therapeutics' Interest & Investment Income surged by 13928.82% in 2023 and then crashed by 5343.09% in 2024.
- Over the past 3 years, Pasithea Therapeutics' Interest & Investment Income (Quarter) stood at -$335317.0 in 2022, then skyrocketed by 151.54% to $172825.0 in 2023, then plummeted by 53.43% to $80483.0 in 2024.
- Its Interest & Investment Income was $80483.0 in Q4 2024, compared to $75076.0 in Q3 2024 and $114407.0 in Q2 2024.